Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder
Status:
Completed
Trial end date:
2018-05-07
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if intranasal ketamine shows initial evidence of
safety, tolerability and efficacy for the treatment of social impairment in individuals with
Autism Spectrum Disorder.